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Abstract 
Lymphoepithelial carcinoma is an undifferentiated nasopharyngeal carcinoma with lymphoid stroma and non-keratinizing squamous cells 
with distinctive clinical, epidemiological and etiological features. Conversely, lymphoepithelioma-like carcinomas (LELCs) are carcinomas 
that arise outside the nasopharynx but resemble a lymphoepithelioma histologically. In this case study, LELC presentation in connective 
tissue (left sternocleidomastoid muscle) is peculiar and unusual, but its diagnosis is supported by histological findings and clinical history, 
especially long disease free survival and no primary lesions in nasopharynx and lung district. We also discuss the pathogenesis, 
hypothesizing an embryological theory. To our knowledge, it could be the first reported case of a primary connective tissue LELC to the 
neck. 
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Figure 1: Axial CT scan of the neck showing a left supraclavicular mass that takes contact with the left jugular vein (narrowed and infiltrated) 
and the left sternocleidomastoid muscle. 
 
 
Figure 2: Cytology.
A 61-year-old man, without comorbidities, presented with a 
swelling on the neck associated with occasional pain. Neck 
ultrasound and computed tomography (CT) scan showed a 6x3 
cm solid expansive mass to the soft tissue, on the left side of 
the neck, contiguous to the omolateral sternocleidomastoid 
muscle. This neoformation appeared non-homogeneous with 
irregular margins and extended from the plane passing through 
the hyoid bone to the left supraclavicular region with 
compression of the thyroid left lobe. Enlarged lymph nodes 
were present on both sides of the neck (Figure 1). 
The patient underwent surgical removal of the mass, with 
sternocleidomastoid muscle, internal jugular vein and lymph 
node dissection on the same side. On macroscopic 
examination, lymph nodes of different sizes to the lower pole 
and a muscle section to the higher pole were recognizable. On 
cut, a 5-cm grey, compact area, tending to friability, within the 
muscle, was examined. 
Histology showed malignant neoplastic tissue invading the 
striated muscle. The tumour was formed of irregular nests and 
trabeculae of large polygonal cells with large nuclei, clumpy 
chromatin and prominent nucleoli and syncytial appearance. 
The nests of epithelial tumour cells were associated with a 
dense and accentuated lymphoid infiltrate (Figure 2). 
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Figure 3: Cytokeratin and EMA immunohistochemistry positive. 
 
Figure 4: Vimentin and lymphoid markers immunohistochemistry negative.
No keratinization could be seen in the tumour. 
Immunohistochemical examination revealed strong 
immunoreactivity for cytokeratins and epithelial membrane 
antigen (EMA) (Figure 3), and negativity for vimentin, CD3 and 
CD20 (Figure 4). 
Conversely, the lymphocytic infiltrate was intensely stained with 
CD45 (leucocyte common antigen—LCA). Using subset 
markers, the large amounts of lymphocytes around the cords of 
carcinoma cells were CD3—positive T lymphocytes and 
CD20—positive B lymphocytes with a clear predominance of 
CD3—positive T lymphocytes, which consisted predominantly of 
CD8—positive cells > CD4—positive cells. Some cells were 
also positive for lysozime and CD68 (macrophages). 
In situ hybridization  (RNA-ISH) and polymerase chain reaction 
(PCR) for detection of Epstein–Barr Virus (EBV) genome were 
negative in both epithelial and lymphocytic populations.  
Lymph nodes were extensively necrotic and metastatic. 
Morphological and immunohistochemical findings fulfilled the 
criteria for the diagnosis of lymphoepithelioma-like carcinoma 
(LELC). 
A rhinofibrolaringoscopy and head-and-neck magnetic 
resonance imaging (MRI) did not show any residual tumour 
mass. 
The patient was followed with CT-scan and MRI, and 
approximately four years after surgery is currently disease free.  
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Lymphoepithelial carcinoma, also known as lymphoepithelioma 
or nasopharyngeal carcinoma type III or Schmincke–Regaud 
tumour, is an undifferentiated nasopharyngeal carcinoma with 
lymphoid stroma and non-keratinizing squamous cells with 
distinctive clinical, epidemiological and etiological features [1]. 
Lymphoepithelioma-like carcinoma is a carcinoma arising 
outside of the nasopharynx, resembling lymphoepithelioma both 
histologically and immunophenotypically. It is a malignant 
epithelial tumour which is characterized by large and uniform 
cells with indistinct cytoplasmic borders, resulting in a syncytial 
growth pattern, round to vescicular and ovoid nuclei, and large 
central nucleoli [2]. Usually, an inflammatory infiltrate rich in 
mature lymphocytes (predominantly CD8+ and T-cells) and 
occasionally eosinophiles are also present, partially obscuring 
the neoplastic epithelial component [3]. 
Conventionally, LELCs have been classified as 'high grade' 
based on poor histological differentiation. LELC localizations 
have been described to the gastrointestinal tract [4], thymus, 
salivary glands [5], uterine cervix [6], skin [7], lung [2], oral 
cavity [8], breast [9], vagina [10], trachea, larynx and vocal cord 
[11], bladder, rarely to the renal pelvis, ureter [12], and only 
once to a scar [13]. 
While there is a strong etiopathological association between 
EBV and lymphoepithelioma, mostly in South-Eastern Asian 
people [14], a connection between LELC and EBV is more 
variable, and usually without any ethnic relevance. However, in 
cases of LELCs occurring in pharyngeal or foregut derivatives, 
the association is much stronger in Asians than in Caucasians 
[2]. Recently, EBV has consistently been observed in LELC of 
specified anatomic sites, such as lung, stomach, thymus and 
salivary gland [5]. 
Circulating serum EBV DNA could be used as a tumour marker 
in the clinical management of LELCs. In fact, in published 
results, patients with a pre-therapy serum EBV DNA > 10.000 
copies/ml had significantly worse survival [15]. Elevated levels 
six–eight weeks after therapy were strongly associated with 
both progression-free and overall survival [16]. 
At present, no validated therapeutic management exists for 
LELC. Surgery represents the best option in localized disease 
[5] sometimes followed with radiotherapy [17], whereas 
chemotherapy is not a conventional option. 
Taxanes, platinum derivatives and 5-fluorouracil combined with 
folinic acid are active drugs [18].  
The LELC has generally been considered to be highly 
radiosensitive, and post-operatory radiotherapy is indicated in 
cases of residual neoplastic tissue at the surgical margins, high-
grade tumour, tumoural infiltration of adjacent organs or 
extensive locoregional diffusion [19, 5]. 
In locally advanced stages, a multimodality approach, including 
surgery, radiotherapy and chemotherapy, is advised [20]. 
Prognosis is linked to stage, grading, radical surgery and 
radiotherapy when the resection is not complete [5]. 
In the differential diagnosis of a connective tissue mass within 
the neck region an LELC should be considered as well as 
nasopharyngeal and metastatic squamous-cell lung 
carcinomas. Histologically, LELC cannot be distinguished from 
them, but clinical history and absence of a primary lesion to the 
nasopharynx or lung could drive the diagnosis. 
Furthermore, a clear distinction between non-keratinizing 
carcinoma and large-cell lymphoma can be difficult. Accurate 
diagnosis is aided by a panel of immunohistochemical stains 
that uses epithelial markers and common leukocyte antigens. 
In the present report, features favouring diagnosis of carcinoma 
include the presence of cohesive cell groups with poorly defined 
cell borders and an immunohistochemical profile of the 
neoplastic cells showing strong positivity for cytokeratin and 
EMA but negativity for LCA. 
This presentation in a connective tissue appears to be very 
peculiar and unusual. To our knowledge, it could be the first 
reported case. 
In our case, a possible primary site was not found, even though 
it cannot be absolutely excluded. However, a primary 
connective tissue LELC could be assumed, based on the 
branchial embryonic remnants origin, particularly from branchial 
cysts arisen from the second branchial arch [21]. In fact, these 
cysts, consisting of lymphoid aggregates that can have either 
squamous or respiratory-type epithelial lining, occur mostly 
along the front edge of the sternocleidomastoid muscle from the 
plane passing through the hyoid bone to the suprasternal notch 
[21, 22, 23]. 
These branchial cysts may develop into branchiogenic 
carcinomas starting from the cystic epithelial lining, which is 
considered a branchial remnant situated along the front edge of 
the sternocleidomastoid muscle, not associated with the 
development of any cancer within five years after diagnosis [24]. 
Finally, the long disease free survival, uncommon for a 
nasopharyngeal carcinoma, is another significant aspect 
suggesting a diagnosis of LELC. 
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